Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Composition and method of using miR-302 precursors as anti-cancer drugs for treating human lung cancer

Composition and method of using miR-302 precursors as anti-cancer drugs for treating human lung cancer

US Patent 10370658 · Granted Aug 6, 2019

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

In-vitro induction of adult stem cell expansion and derivation2023
In-vitro induction of adult stem cell expansion and derivation2023
Trimethylglycylglycerin compositions and their use in developing anti-cancer dru2022
Composition and method of using miR-302 precursors as drugs for treating Alzheim2019
Composition for producing microRNA precursors as drugs for enhancing wound heali2019
Composition for producing microRNA precursors as drugs for enhancing wound heali2019
Use of monosaccharide-like glycylated sugar alcohol compositions for designing a2018
Use of monosaccharide-like glycylated sugar alcohol compositions for designing a2018
Use of novel monosaccharide-like glycylated sugar alcohol compositions for desig2018
Use of novel monosaccharide-like glycylated sugar alcohol compositions for desig2018
Use of microRNA precursors as drugs for inducing CD34-positive adult stem cell e2018
Use of microRNA precursors as drugs for inducing CD34-positive adult stem cell e2018